Invesco NASDAQ Biotechnology ETF
IBBQ
9 hedge funds and large institutions have $44.8M invested in Invesco NASDAQ Biotechnology ETF in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
29% more funds holding
Funds holding: 7 → 9 (+2)
3.14% less ownership
Funds ownership: 95.77% → 92.63% (-3.1%)
29% less capital invested
Capital invested by funds: $63.5M → $44.8M (-$18.7M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$4.94M |
| 2 |
FTUS
Flow Traders U.S.
New York
|
+$527K |
| 3 |
CGL
Clarius Group LLC
Seattle,
Washington
|
+$494K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$10.4M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.33M |
| 3 |
JP Morgan Chase
New York
|
-$4.25M |
| 4 |
Morgan Stanley
New York
|
-$1.32M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Bank of America
Charlotte,
North Carolina
| $10.2M | – | – | – |
|
2
Citigroup
New York
| $10.2M | – | – | – |
|
|
3
Morgan Stanley
New York
| $8.96M | -$1.32M | -50,000 | -13% |
|
|
4
Mirae Asset Global Investments
Seoul,
South Korea
| $8.03M | +$4.94M | +187,596 | +149% |
|
|
5
JP Morgan Chase
New York
| $6.11M | -$4.25M | -161,220 | -40% |
|
|
FTUS
6
Flow Traders U.S.
New York
| $512K | +$527K | +20,000 | New |
|
|
CGL
7
Clarius Group LLC
Seattle,
Washington
| $480K | +$494K | +18,752 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $240K | -$8.33M | -316,245 | -97% |
|
|
9
Osaic Holdings
Scottsdale,
Arizona
| $5K | +$5.27K | +200 | New |
|
|
CS
10
Credit Suisse
Zurich,
Switzerland
| – | -$10.4M | -400,000 | Closed |
|
IBBQ Hedge Fund Activity: Q3 2021 in Review
9 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q3 2021, worth a combined $44.8M — down 29% from $63.5M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IBBQ positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Mirae Asset Global Investments, adding an estimated $4.94M. The largest seller was Credit Suisse, exiting entirely with an estimated $10.4M sold.
- 9 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q3 2021, up from 7 in Q2 2021.
- Funds reported $44.8M of Invesco NASDAQ Biotechnology ETF stock for Q3 2021, down 29% quarter-over-quarter.
- 3 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q3 2021 and 1 closed out, a net change of +2 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q3 2021 was Mirae Asset Global Investments, an estimated $4.94M added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q3 2021 was Credit Suisse, an estimated $10.4M sold.
Based on aggregated 13F filings for Q3 2021.